What is Mend?
Mend operates at the intersection of medical recovery and digital health, offering a comprehensive suite of clinically proven nutrition formulas and remote coaching programs. The company's platform is specifically engineered to support patients through complex surgical recovery, weight management, and long-term lifestyle optimization. By leveraging science-backed protocols, Mend provides a scalable solution that addresses the critical need for improved patient outcomes in both clinical and home-based settings. Their market position is defined by a unique dual-approach: high-quality nutritional products paired with digital health coaching, which has garnered trust among leading surgeons and healthcare providers. This integration allows Mend to effectively manage the patient journey, ensuring that recovery is not only faster but also more sustainable through data-driven health interventions.
How much funding has Mend raised?
Mend has raised a total of $24.9M across 2 funding rounds:
Series A
$15M
Stock/Share Issuance
$9.9M
Series A (2023): $15M with participation from iSelect Fund Management, Keen Growth Capital, S2G Ventures, and Touchdown Ventures
Stock/Share Issuance (2026): $9.9M, investors not publicly disclosed
Key Investors in Mend
iSelect Fund Management
A venture capital firm focused on the intersection of food, health, and AgTech, dedicated to addressing global nutrition challenges through innovative investments.
Keen Growth Capital
An impact investing fund specializing in early-stage food and beverage brands that aim to enhance societal health and wellness through superior nutritional products.
S2G Ventures
A multi-stage food and agriculture venture fund that invests across the entire supply chain, targeting companies that meet the shifting demands for sustainable and healthy food systems.
What's next for Mend?
With this latest round of financing, Mend is well-positioned to accelerate its expansion into broader healthcare markets and enhance its digital health infrastructure. The strategic focus will likely center on scaling its remote recovery support programs and deepening its penetration within hospital networks that prioritize value-based care. As the demand for personalized, evidence-based health solutions continues to rise, Mend is poised to leverage its capital to refine its product offerings and potentially explore new therapeutic areas. The company's ability to maintain high standards of clinical efficacy while scaling its operations will be the primary driver of its future success in the competitive health-tech ecosystem.
See full Mend company page
